Skip to main content

Table 1 Baseline characteristics of the study population

From: Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation

 

Total

N = 243

SV group

N = 40

SMV group

N = 25

Mixed group

N = 178

P value

Demographics and clinical characteristics

Age*

54.6 (12.0)

54.2 (11.0)

62.5 (11.6)

53.6 (11.9)

0.002

Sex (Male)

155 (63.8)

26 (65.0)

20 (80.0)

109 (61.2)

0.185

 Etiology

0.277

  Virus related

168 (69.1)

28 (70.0)

14 (56.0)

126 (70.8)

  Alcohol related

22 (9.05)

5 (12.5)

2 (8.00)

15 (8.43)

  AIH

25 (10.3)

3 (7.50)

2 (8.00)

20 (11.2)

  Others

28 (11.5)

4 (10.0)

7 (28.0)

17 (9.55)

 TIPS indication

 < 0.001

  Variceal bleeding

212 (87.2)

31 (77.5)

17 (68.0)

164 (92.1)

  Refractory ascites

31 (12.8)

9 (22.5)

8 (32.0)

14 (7.87)

Child–Pugh score*

7.53 (1.61)

7.15 (1.53)

7.96 (1.10)

7.55 (1.67)

0.131

 Child–Pugh class

0.065

  A

62 (26.2)

13 (32.5)

3 (12.0)

46 (26.7)

  B

153 (64.6)

25 (62.5)

22 (88.0)

106 (61.6)

  C

22 (9.28)

2 (5.00)

0 (0.00)

20 (11.6)

MELD score*

11.9 (3.68)

11.4 (3.10)

13.0 (3.45)

11.9 (3.82)

0.238

MELD-Na score*

12.8 (4.71)

12.3 (4.40)

14.2 (4.77)

12.7 (4.76)

0.263

Radiological findings

 Ascites

0.005

  Mild

84 (34.9)

10 (25.6)

3 (12.0)

71 (40.1)

  Moderate

39 (16.2)

9 (23.1)

5 (20.0)

25 (14.1)

  Severe

66 (27.4)

6 (15.4)

13 (52.0)

47 (26.6)

Spontaneous porto-systemic shunt (Yes)

94 (38.7)

13 (32.5)

11 (44.0)

70 (39.3)

0.828

PV diameter (mm)*

15.4 (3.28)

14.5 (2.69)

15.3 (3.99)

15.6 (3.28)

0.172

Laboratory parameters*

Bilirubin (µmol/L)

27.9 (28.3)

22.8 (11.4)

27.0 (13.1)

29.3 (32.3)

0.419

Albumin (g/L)

31.3 (5.53)

31.9 (5.37)

29.3 (5.53)

31.4 (5.54)

0.144

ALT (U/L)

37.1 (80.0)

32.8 (22.4)

37.6 (30.5)

38.0 (92.6)

0.935

Creatinine (µmol/L)

76.9 (60.6)

74.5 (27.3)

92.6 (75.7)

75.1 (63.7)

0.391

Sodium (mmol/L)

139 (4.43)

138 (3.94)

140 (5.61)

139 (4.36)

0.576

Prothrombin time (s)

16.8 (2.49)

16.5 (2.52)

17.0 (1.69)

16.8 (2.58)

0.703

INR

1.39 (0.26)

1.36 (0.26)

1.41 (0.18)

1.39 (0.27)

0.679

TIPS procedure

 Stent diameter

0.520

  6 mm

108 (44.4)

19 (47.5)

12 (48.0)

77 (43.3)

  7 mm

87 (35.8)

16 (40.0)

6 (24.0)

65 (36.5)

  8 mm

48 (19.8)

5 (12.5)

7 (28.0)

36 (20.2)

Pre-TIPS PPG*

36.8 (7.63)

34.8 (5.81)

33.7 (10.7)

37.5 (7.51)

0.080

Post-TIPS PPG*

15.9 (5.41)

15.3 (4.20)

13.1 (7.39)

16.3 (5.33)

0.088

 Portography

0.169

  Through SV

221 (90.9)

37 (92.5)

21 (84.0)

164 (92.1)

  Through SMV

22 (9.1)

3 (7.5)

5 (16.0)

14 (7.9)

 Puncture site

 < 0.001

  Left branch

112 (46.1)

7 (17.5)

17 (68.0)

88 (49.4)

  Right branch

131 (53.9)

33 (82.5)

8 (32.0)

90 (50.6)

  Embolization

166 (68.3)

29 (72.5)

15 (60.0)

122 (68.5)

0.569

  1. *Data were expressed as means and standard deviation; Other data were presented as frequencies and percentages
  2. AIH autoimmune hepatitis, CTPV cavernous transformation of portal vein, MELD model for end-stage liver disease, PV portal vein, SV splenic vein, SMV superior mesenteric vein, ALT alanine aminotransferase, INR international normalized ratio, PPG portal pressure gradient